0001209191-18-020205.txt : 20180316 0001209191-18-020205.hdr.sgml : 20180316 20180316164022 ACCESSION NUMBER: 0001209191-18-020205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack David F CENTRAL INDEX KEY: 0001573072 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 18696149 MAIL ADDRESS: STREET 1: 39 YORKSHIRE DR CITY: OAKLAND STATE: CA ZIP: 94618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET STREET 2: SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-15 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001573072 Novack David F C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710 0 1 0 0 Senior Vice President Common Stock 2018-03-15 4 S 0 16109 16.3017 D 0 D This transaction was executed in multiple trades at prices ranging from $16.300 to $16.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ David Novack 2018-03-16